C7A.00
BillableMalignant carcinoid tumor of unspecified site
Malignant carcinoid tumor of unspecified site
Coding Notes
Excludes 2
Conditions not included here, but the patient may have both
- •malignant pancreatic islet cell tumorsC25.4
- Merkel cell carcinoma (C4A.-)
Use Additional Code
Additional codes that should follow this code
- code to identify any associated endocrine syndrome, such as:
- •carcinoid syndromeE34.00
Code Also
A second code may be required; sequencing depends on circumstances
Related Codes(3)
Also Known As / Clinical Terms(83)
SNOMED CT
- Tricuspid stenosis with regurgitation703319006
- Tricuspid valve stenosis with insufficiency703319006
- Neuroendocrine tumor1288045008
- Neuroendocrine tumour1288045008
- Well-differentiated neuroendocrine tumor1288045008
- Well-differentiated neuroendocrine tumour1288045008
- Enterochromaffin cell carcinoid tumor1288046009
- Enterochromaffin cell carcinoid tumour1288046009
- Enterochromaffin cell tumor1288046009
- Enterochromaffin cell tumour1288046009
- Metastatic neuroendocrine tumor1290060007
- Metastatic neuroendocrine tumour1290060007
- Metastatic well-differentiated neuroendocrine tumor1290060007
- Metastatic well-differentiated neuroendocrine tumour1290060007
- Neuroendocrine tumor of intestine1290070009
- Neuroendocrine tumour of intestine1290070009
- Well-differentiated neuroendocrine tumor of intestine1290070009
- Well-differentiated neuroendocrine tumour of intestine1290070009
- Neuroendocrine tumor of gastrointestinal tract1290071008
- Neuroendocrine tumour of gastrointestinal tract1290071008
- Well-differentiated neuroendocrine tumor of gastrointestinal tract1290071008
- Well-differentiated neuroendocrine tumour of gastrointestinal tract1290071008
- Tricuspid valve stenosis with regurgitation due to neuroendocrine tumor1290077007
- Tricuspid valve stenosis with regurgitation due to neuroendocrine tumour1290077007
- Tricuspid valve regurgitation due to neuroendocrine tumor1290078002
- Tricuspid valve regurgitation due to neuroendocrine tumour1290078002
- Tricuspid valve stenosis due to neuroendocrine tumor1290079005
- Tricuspid valve stenosis due to neuroendocrine tumour1290079005
- Metastatic well-differentiated neuroendocrine tumor to lung1343682000
- Metastatic well-differentiated neuroendocrine tumour to lung1343682000
- Malignant carcinoid tumor of left lung145298771000119104
- Malignant carcinoid tumour of left lung145298771000119104
- Malignant carcinoid tumor of right lung793197981000119106
- Malignant carcinoid tumour of right lung793197981000119106
- Metastatic well-differentiated neuroendocrine tumor to left lung386085001000119102
- Metastatic well-differentiated neuroendocrine tumour to left lung386085001000119102
- Metastatic well-differentiated neuroendocrine tumor to regional lymph node140633841000119106
- Metastatic well-differentiated neuroendocrine tumour to regional lymph node140633841000119106
- Metastatic well-differentiated neuroendocrine tumor to right lung543826841000119109
- Metastatic well-differentiated neuroendocrine tumour to right lung543826841000119109
- Poorly differentiated malignant carcinoid tumor134871000119100
Clinical Terms
- Malignant carcinoid tumour of right lung
- Metastatic well-differentiated neuroendocrine tumour to left lung
- Tricuspid valve stenosis due to neuroendocrine tumour
- Tricuspid valve stenosis with regurgitation due to neuroendocrine tumour
- Enterochromaffin cell tumour
- Well-differentiated neuroendocrine tumor
- Neuroendocrine tumor of gastrointestinal tract
- Poorly differentiated malignant carcinoid tumor
- Neuroendocrine tumor of intestine
- Tricuspid valve regurgitation due to neuroendocrine tumor
- Well-differentiated neuroendocrine tumour of intestine
- Metastatic well-differentiated neuroendocrine tumour
- Metastatic well-differentiated neuroendocrine tumor
- Tricuspid valve stenosis due to neuroendocrine tumor
- Well-differentiated neuroendocrine tumor of intestine
- Metastatic well-differentiated neuroendocrine tumor to lung
- Metastatic well-differentiated neuroendocrine tumor to regional lymph node
- Well-differentiated neuroendocrine tumour
- Metastatic well-differentiated neuroendocrine tumour to lung
- Enterochromaffin cell carcinoid tumour
- Tricuspid valve stenosis with insufficiency
- Tricuspid valve stenosis with regurgitation due to neuroendocrine tumor
- Well-differentiated neuroendocrine tumour of gastrointestinal tract
- Metastatic well-differentiated neuroendocrine tumor to left lung
- Metastatic well-differentiated neuroendocrine tumour to regional lymph node
- Neuroendocrine tumor
- Enterochromaffin cell tumor
- Neuroendocrine tumour of gastrointestinal tract
- Well-differentiated neuroendocrine tumor of gastrointestinal tract
- Malignant carcinoid tumour of left lung
- Tricuspid valve regurgitation due to neuroendocrine tumour
- Enterochromaffin cell carcinoid tumor
- Metastatic well-differentiated neuroendocrine tumour to right lung
- Metastatic neuroendocrine tumour
- Malignant carcinoid tumor of left lung
- Metastatic neuroendocrine tumor
- Malignant carcinoid tumor of right lung
- Tricuspid stenosis with regurgitation
- Metastatic well-differentiated neuroendocrine tumor to right lung
- Neuroendocrine tumour of intestine
- Neuroendocrine tumour
Frequently Asked Questions
What is the ICD-10 code for malignant carcinoid tumor of unspecified site?
The ICD-10-CM code for malignant carcinoid tumor of unspecified site is C7A.00. The full clinical description is "Malignant carcinoid tumor of unspecified site". C7A.00 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code C7A.00 mean?
ICD-10-CM code C7A.00 represents “Malignant carcinoid tumor of unspecified site”. It is classified under Chapter 2: Neoplasms and is a billable/specific code that can be used on a claim.
Is C7A.00 a billable code?
Yes, C7A.00 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is C7A.00 in?
C7A.00 is in Chapter 2: Neoplasms (codes C00-D49).
Are additional codes required with C7A.00?
Yes, when using C7A.00, also report: any associated endocrine syndrome, such as:; carcinoid syndrome (E34.00).
What SNOMED CT codes does C7A.00 map to?
C7A.00 maps to 16 SNOMED CT concepts: 1288046009, 145298771000119104, 793197981000119106, 1290060007, 386085001000119102, and 11 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for C7A.00?
C7A.00 is linked to 1 UMLS Concept Unique Identifier: C2845976. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does C7A.00 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like malignant carcinoid tumor of unspecified site affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of C7A.00?
There is no direct ICD-11 mapping available for C7A.00 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.